Contact Information
Company Information
Annual Revenue
10012000.0
Technologies
Outlook
Microsoft Office 365
Mobile Friendly
Google Font API
Vimeo
Keywords
biotechnology
central nervous system
innovative signaling specific drugs
cb1 receptor
allosteric modulator
cannabis addiction
cognitive disorders
down syndrome
fragil x syndrom
obesity
metabolic disorders
cannabis use disorders
biotechnology research
aelis farma
cannabinoid receptor
cb1-ssi
pharmacological inhibitors
cannabis-related disorders
cognitive deficits
therapeutic solutions
clinical trials
innovative drug development
brain diseases
preclinical development
molecular target
mechanism of action
aef0117
aef0217
drug candidates
neurodevelopmental disorders
mental health
cognitive impairment
brain receptor signaling
pharmaceutical research
addiction treatment
drug efficacy
safety profiles
therapeutic index
high potency
drug discovery
fda ind
clinical phase
neurological disorders
regulatory compliance
healthcare innovations
research collaboration
therapeutic tools
unmet medical needs
primary receptor
neuroscience research
patient recruitment
emergency room visits
substance use disorders
medical biotechnology
eu funding
investor relations
biotechnology industry
health care
health
wellness & fitness
hospital & health care
Get Full Contact Details
Subscribe to reveal email addresses and export contacts.
View Plans